Court invalidates Illumina patents in Ariosa row

Ariosa Diagnostics, a subsidiary of Swiss healthcare firm Roche, has won a patent dispute with American biotechnology firm Illumina.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Got a patent, now where to validate?

22 March 2021 For smaller companies and universities, deciding where to validate a pharma patent can be difficult. Sarah Kostiuk-Smith of Mewburn Ellis looks at the options within the European Patent Convention countries.

Americas

Illumina and Sequenom take on Ariosa in DNA patent infringement case

17 May 2018 Illumina and Sequenom have filed a patent infringement case against Ariosa Diagnostics for a patent covering DNA testing in pregnant women.

Biotechnology

BGI takes Illumina to court over patent infringement in US

29 May 2019 A subsidiary of China-based genome sequencing company BGI has filed a patent infringement suit against a US competitor.

More on this story

Big Pharma

Got a patent, now where to validate?

Americas

Illumina and Sequenom take on Ariosa in DNA patent infringement case

17 May 2018 Illumina and Sequenom have filed a patent infringement case against Ariosa Diagnostics for a patent covering DNA testing in pregnant women.

Biotechnology

BGI takes Illumina to court over patent infringement in US

29 May 2019 A subsidiary of China-based genome sequencing company BGI has filed a patent infringement suit against a US competitor.

More on this story

Big Pharma

Got a patent, now where to validate?

Americas

Illumina and Sequenom take on Ariosa in DNA patent infringement case

17 May 2018 Illumina and Sequenom have filed a patent infringement case against Ariosa Diagnostics for a patent covering DNA testing in pregnant women.

Biotechnology

BGI takes Illumina to court over patent infringement in US

29 May 2019 A subsidiary of China-based genome sequencing company BGI has filed a patent infringement suit against a US competitor.